PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
-5.78%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$211M
AUM Growth
+$211M
(-12%)
Cap. Flow
+$3.94M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
99.11%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
VIGL
Vigil Neuroscience
VIGL
|
$3.94M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $108M | 51.15% | 852,708 | – | – |
|
2
Vaxcyte
PCVX
$4B
| $26.8M | 12.7% | 1,111,485 | – | – |
|
3
Rallybio
RLYB
$22.4M
| $15.9M | 7.5% | 2,271,311 | – | – |
|
|
FUSN
4
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $12.4M | 5.88% | 1,598,377 | – | – |
|
|
EXAI
5
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $11.1M | 5.26% | 772,285 | – | – |
|
6
Arcutis Biotherapeutics
ARQT
$1.86B
| $11M | 5.19% | 569,041 | – | – |
|
|
AKUS
7
DELISTED
Akouos, Inc. Common Stock
AKUS
| $8.52M | 4.03% | 1,794,088 | – | – |
|
|
INZY
8
DELISTED
Inozyme Pharma
INZY
| $6.51M | 3.08% | 1,591,154 | – | – |
|
9
Bolt Biotherapeutics
BOLT
$9.85M
| $5.18M | 2.45% | 1,891,467 | – | – |
|
|
VIGL
10
DELISTED
Vigil Neuroscience
VIGL
| $3.94M | 1.86% | +560,595 | New | +$3.94M |
|
11
Aligos Therapeutics
ALGS
$73.3M
| $1.89M | 0.89% | 876,548 | – | – |
|